2973 Stock Overview
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sanai Health Industry Group Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.36 |
| 52 Week High | HK$0.38 |
| 52 Week Low | HK$0.25 |
| Beta | -0.25 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 7.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2973 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | 10.6% | -4.3% | 2.1% |
| 1Y | n/a | 3.1% | 3.4% |
Return vs Industry: Insufficient data to determine how 2973 performed against the Hong Kong Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 2973 performed against the Hong Kong Market.
Price Volatility
| 2973 volatility | |
|---|---|
| 2973 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in HK Market | 13.1% |
| 10% least volatile stocks in HK Market | 3.3% |
Stable Share Price: 2973 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 2973's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 68 | n/a | www.1889hk.com |
Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. It operates through three segments: Pharmaceutical Products, Finance Leasing, and Genetic Testing and Molecular Diagnostic Services. The company also engages in development, manufacturing, marketing, and sale of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services.
Sanai Health Industry Group Company Limited Fundamentals Summary
| 2973 fundamental statistics | |
|---|---|
| Market cap | HK$45.11m |
| Earnings (TTM) | HK$20.39m |
| Revenue (TTM) | HK$133.62m |
2.2x
P/E Ratio0.3x
P/S RatioIs 2973 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2973 income statement (TTM) | |
|---|---|
| Revenue | CN¥122.10m |
| Cost of Revenue | CN¥86.97m |
| Gross Profit | CN¥35.13m |
| Other Expenses | CN¥16.50m |
| Earnings | CN¥18.63m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 30, 2024
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 28.77% |
| Net Profit Margin | 15.26% |
| Debt/Equity Ratio | 22.6% |
How did 2973 perform over the long term?
See historical performance and comparison